Vaccination With Idiotype-KLH Loaded Dendritic Cells. A Phase I Study for Patients With Multiple Myeloma
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Specific T-cell proliferation/cytokine secretion
No
Susanne Gretzinger, MD
Principal Investigator
University Hospital Dresden
Germany: not applicable since not necessary
MyelomVak
NCT00988312
March 2002
March 2004
Name | Location |
---|